165 related articles for article (PubMed ID: 17498699)
1. Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?
Butsch PO; Cudkowicz ME
Exp Neurol; 2007 Jul; 206(1):11-5. PubMed ID: 17498699
[No Abstract] [Full Text] [Related]
2. The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons.
Chung JY; Kim HJ; Kim M
BMC Neurosci; 2015 Feb; 16(1):1. PubMed ID: 25655275
[TBL] [Abstract][Full Text] [Related]
3. Edaravone in ALS.
Takahashi R
Exp Neurol; 2009 Jun; 217(2):235-6. PubMed ID: 19285071
[No Abstract] [Full Text] [Related]
4. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model.
Grunfeld JF; Barhum Y; Blondheim N; Rabey JM; Melamed E; Offen D
Exp Neurol; 2007 Mar; 204(1):260-3. PubMed ID: 17174305
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron disease: a chemical perspective.
Wood LK; Langford SJ
J Med Chem; 2014 Aug; 57(15):6316-31. PubMed ID: 24694032
[TBL] [Abstract][Full Text] [Related]
8. GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD1) gene.
Mitsumoto H
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Mar; 1(2):69-70. PubMed ID: 11467052
[No Abstract] [Full Text] [Related]
9. Neurobiology. Stay the executioner's hand.
Gurney ME; Tomasselli AG; Heinrikson RL
Science; 2000 Apr; 288(5464):283-4. PubMed ID: 10777410
[No Abstract] [Full Text] [Related]
10. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
Kadoyama K; Funakoshi H; Ohya W; Nakamura T
Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
12. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
13. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
[TBL] [Abstract][Full Text] [Related]
14. Cdk5 sinks into ALS.
Patzke H; Tsai LH
Trends Neurosci; 2002 Jan; 25(1):8-10. PubMed ID: 11801324
[TBL] [Abstract][Full Text] [Related]
15. Anti-ALS activity of alsin, the product of the ALS2 gene, and activity-dependent neurotrophic factor.
Matsuoka M; Nishimoto I
Neurodegener Dis; 2005; 2(3-4):135-8. PubMed ID: 16909018
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
Klivenyi P; Ferrante RJ; Matthews RT; Bogdanov MB; Klein AM; Andreassen OA; Mueller G; Wermer M; Kaddurah-Daouk R; Beal MF
Nat Med; 1999 Mar; 5(3):347-50. PubMed ID: 10086395
[TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Abe K
Neurol Res; 2003 Mar; 25(2):195-200. PubMed ID: 12635522
[TBL] [Abstract][Full Text] [Related]
18. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis.
Kupershmidt L; Weinreb O; Amit T; Mandel S; Carri MT; Youdim MB
FASEB J; 2009 Nov; 23(11):3766-79. PubMed ID: 19638399
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin does not preserve motor neurons in a mouse model of familial ALS.
Grignaschi G; Zennaro E; Tortarolo M; Calvaresi N; Bendotti C
Amyotroph Lateral Scler; 2007 Feb; 8(1):31-5. PubMed ID: 17364433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
